´ëÇѳúÁ¹ÁßÇÐȸ The 9th JKJSC (Japan-Korea Joint Stroke Conference, ÇÑÀϳúÁ¹ÁßÇÐȸ) 9/14~16 : 2019-11-14±³À°ÀÏÀÚ : 2019-11-14
±³À°Àå¼Ò : ÀÎõ ¼ÛµµÄÁº¥½Ã¾Æ ÇÁ¸®¹Ì¾öº¼·ý
±³À°ÁÖÁ¦ :
The 9th JKJSC (Japan-Korea Joint Stroke Conference, ÇÑÀϳúÁ¹ÁßÇÐȸ) 9/14~16ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-2277-1919
À̸ÞÀÏ :
stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 300,000¿ø
ºñ°í 1. »çÀüµî·Ï (M.D 25¸¸¿ø/Trainee 12¸¸¿ø/ Allied Health Professionals(°£È£»ç,¾à»ç,±â»ç) 5¸¸¿ø, Accompanying Person 5¸¸¿ø 2. ÇöÀåµî·Ï (M.D 30¸¸¿ø/Trainee 15¸¸¿ø/ Allied Health Professionals(°£È£»ç,¾à»ç,±â»ç) 6¸¸¿ø, Accompanying Person 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-14 Room A 13:00~13:25 Anticoagulation treatment for prior stroke patients with NVAF and renal impairment. Why do we consider renal outcomes? Ȳ¾çÇÏ(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-14 Room A 13:25~13:50 Consistent safety outcomes of rivaroxaban in real world: Focus on renal impairment ±è¹üÁØ(°æÈñÀÇ´ë)
ÈÞ½Ä 11-14 Room A 13:50~14:00 Intermission ()
±âŸ 11-14 Room A 14:00~14:20 Opening Ceremony & General Assembly ()
ÈÞ½Ä 11-14 Room A 14:20~14:30 Intermission ()
±³À°½Ã°£ 11-14 Room A 14:30~14:50 Korean and Japan stroke care going forward ³ëÀç±Ô(±¹±º¼öµµº´¿ø)
±³À°½Ã°£ 11-14 Room A 14:50~15:10 CRCS-K (Clinical Research Center for Stroke – Korea) ¹èÈñÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-14 Room A 15:10~15:30 FSR (Fukuoka Stroke Registry) Tetsuro Ago(Kyushu University, Japan)
±³À°½Ã°£ 11-14 Room A 15:30~15:50 K-ATTENTION (Korean ATrial firbrillaTion EvaluatioN regisTry in Ischemic strOke patieNts) ¼¿ì±Ù(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-14 Room A 15:50~16:00 Discussion À̱¤È£, Yoshiaki Itoh(KMPÇコÄɾî(À̱¤È£), (Osaka City University, Japan(Yoshiaki Itoh))
ÈÞ½Ä 11-14 Room A 16:00~16:10 Coffee Break ()
±³À°½Ã°£ 11-14 Room A 16:10~17:00 Scientific Session 1 Tetsuro Ago, ¼®½ÂÇÑ(Kyushu University, Japan(Tetsuro Ago), ¿ø±¤ÀÇ´ë(¼®½ÂÇÑ))